CpG Island Elements for Stable Transgene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating cultured mammalian cell lines producing high levels of therapeutic proteins are inefficient, time-consuming, and expensive due to chromatin position effects, and the tissue-specificity of Locus Control Regions (LCRs) limits their applicability.
Innovation Solution
The use of extended methylation-free CpG islands from ribosomal protein gene promoters, such as those from the rps3 gene, to create a polynucleotide sequence that enhances gene expression by maintaining a transcriptionally active chromatin environment when linked to a heterologous promoter, thereby increasing the stability and level of transgene expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional gene amplification methods are used to produce high levels of therapeutic proteins, then protein production levels can be increased, but the process becomes time-consuming and expensive
Solution Approach 1:
The invention extracts the essential chromatin-opening function from complex LCR regions and concentrates it into a compact CpG island element. This extracted element maintains the ability to establish open chromatin domains without requiring the full LCR structure, thereby achieving high expression levels while eliminating the time-consuming aspects of traditional methods
Solution Approach 2:
The invention changes the fundamental parameter of chromatin structure by introducing methylated CpG islands that resist DNA methylation. This parameter change creates a stable open chromatin configuration that maintains high transcriptional activity without requiring prolonged selection periods, thus reducing both time and cost while maintaining high protein production
2Productivity
If Locus Control Regions (LCRs) are used to enhance gene expression, then expression levels can be increased, but tissue-specificity limits their applicability
Solution Approach 1:
The CpG island element functions universally across different cell types and tissues by establishing open chromatin domains through a mechanism that is not restricted to specific tissue contexts. This universal mechanism allows the same element to drive high expression levels in diverse cellular environments, overcoming the tissue-specificity limitation of LCRs
Solution Approach 2:
The CpG island acts as an intermediary element that mediates between the promoter and the broader chromatin environment. It establishes open chromatin domains that facilitate transcription without being constrained by tissue-specific regulatory mechanisms, thereby enabling broad applicability across different tissue types while maintaining high expression levels
3Productivity
If random integration of transgenes is performed, then gene expression can occur, but chromatin position effects cause variability in expression patterns
Solution Approach 1:
The CpG island element performs preliminary action by establishing an open chromatin domain configuration before transcription begins. This pre-established open chromatin environment ensures that regardless of the integration location, the transgene immediately encounters a transcriptionally competent environment, thereby eliminating position effects and ensuring reproducible expression
Solution Approach 2:
The CpG island provides beforehand cushioning by creating a protective open chromatin domain that shields the transgene from surrounding heterochromatin. This protective effect counteracts potential silencing influences from neighboring regions, ensuring stable and reproducible expression regardless of integration site variability
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
The invention relates to genetic elements capable of improving the levels of expression of operably-linked transcription units. In particular, said genetic elements are derived from the 5' untranslated regions of ribosomal protein genes and may comprise a CpG island. Also provided are vectors and host cells comprising said genetic elements and methods of use to obtain high levels of recombinant gene expression.